This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1992 Jul 2;358(6381):15-6.

doi: 10.1038/358015a0.

Cancer. p53, guardian of the genome

D P Lane

PMID: 1614522
DOI: 10.1038/358015a0

Comment

Cancer. p53, guardian of the genome

D P Lane. Nature. 1992.

. 1992 Jul 2;358(6381):15-6.

doi: 10.1038/358015a0.

Author

D P Lane

PMID: 1614522
DOI: 10.1038/358015a0

No abstract available

PubMed Disclaimer

Comment in

Checkpoint policing by p53.
Carr AM, Green MH, Lehmann AR. Carr AM, et al. Nature. 1992 Oct 8;359(6395):486-7. doi: 10.1038/359486a0. Nature. 1992. PMID: 1406967 No abstract available.

Comment on

Amplification of a gene encoding a p53-associated protein in human sarcomas.
Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Oliner JD, et al. Nature. 1992 Jul 2;358(6381):80-3. doi: 10.1038/358080a0. Nature. 1992. PMID: 1614537
Wild-type p53 activates transcription in vitro.
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. Farmer G, et al. Nature. 1992 Jul 2;358(6381):83-6. doi: 10.1038/358083a0. Nature. 1992. PMID: 1614538

Similar articles

Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q. Jin S, et al. Oncogene. 2001 May 10;20(21):2683-90. doi: 10.1038/sj.onc.1204390. Oncogene. 2001. PMID: 11420680
Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. Rouault JP, et al. Nat Genet. 1996 Dec;14(4):482-6. doi: 10.1038/ng1296-482. Nat Genet. 1996. PMID: 8944033
Regulation of DNA damage recognition and nucleotide excision repair: another role for p53.
Ford JM. Ford JM. Mutat Res. 2005 Sep 4;577(1-2):195-202. doi: 10.1016/j.mrfmmm.2005.04.005. Mutat Res. 2005. PMID: 15927209 Review.
Global genome repair is required to activate KIN17, a UVC-responsive gene involved in DNA replication.
Masson C, Menaa F, Pinon-Lataillade G, Frobert Y, Chevillard S, Radicella JP, Sarasin A, Angulo JF. Masson C, et al. Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):616-21. doi: 10.1073/pnas.0236176100. Epub 2003 Jan 13. Proc Natl Acad Sci U S A. 2003. PMID: 12525703 Free PMC article.
[Tumor suppressor gene p53--function and significance in gastroenterology].
Schoppmeyer K, Keim V, Mössner J. Schoppmeyer K, et al. Z Gastroenterol. 1997 Jun;35(6):491-509. Z Gastroenterol. 1997. PMID: 9281241 Review. German.

See all similar articles

Cited by

Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer.
Bai R, Li D, Shi Z, Fang X, Ge W, Zheng S. Bai R, et al. J Exp Clin Cancer Res. 2013 May 29;32(1):35. doi: 10.1186/1756-9966-32-35. J Exp Clin Cancer Res. 2013. PMID: 23718802 Free PMC article.
TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy.
Chiaretti S, Brugnoletti F, Tavolaro S, Bonina S, Paoloni F, Marinelli M, Patten N, Bonifacio M, Kropp MG, Sica S, Guarini A, Foà R. Chiaretti S, et al. Haematologica. 2013 May;98(5):e59-61. doi: 10.3324/haematol.2012.076786. Epub 2013 Feb 12. Haematologica. 2013. PMID: 23403321 Free PMC article. No abstract available.
Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins.
Schäfer M, Semmler ML, Bernhardt T, Fischer T, Kakkassery V, Ramer R, Hein M, Bekeschus S, Langer P, Hinz B, Emmert S, Boeckmann L. Schäfer M, et al. Cancers (Basel). 2021 Apr 7;13(8):1770. doi: 10.3390/cancers13081770. Cancers (Basel). 2021. PMID: 33917267 Free PMC article. Review.
Editorial: Advances in wild type and mutant p53 research in cancer.
Hernández-de la Cruz ON, Domínguez-Gómez G, Deb M, Díaz-Chávez J. Hernández-de la Cruz ON, et al. Front Mol Biosci. 2022 Nov 10;9:1064280. doi: 10.3389/fmolb.2022.1064280. eCollection 2022. Front Mol Biosci. 2022. PMID: 36438655 Free PMC article. No abstract available.
Tumor-Suppressor Functions of the TP53 Pathway.
Aubrey BJ, Strasser A, Kelly GL. Aubrey BJ, et al. Cold Spring Harb Perspect Med. 2016 May 2;6(5):a026062. doi: 10.1101/cshperspect.a026062. Cold Spring Harb Perspect Med. 2016. PMID: 27141080 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal